BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23453995)

  • 1. L8. Animal models of ANCA associated vasculitis: the contribution of autoantibodies and autoreactive T cells.
    Heeringa P
    Presse Med; 2013 Apr; 42(4 Pt 2):515-7. PubMed ID: 23453995
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.
    Nagai M; Hirayama K; Ebihara I; Shimohata H; Kobayashi M; Koyama A
    Nephron Clin Pract; 2011; 118(4):c339-45. PubMed ID: 21293157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in ANCA-associated vasculitis.
    Wiik AS
    Rheum Dis Clin North Am; 2010 Aug; 36(3):479-89. PubMed ID: 20688245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine.
    Nagao T; Kusunoki R; Iwamura C; Kobayashi S; Yumura W; Kameoka Y; Nakayama T; Suzuki K
    Microbiol Immunol; 2013 Sep; 57(9):640-50. PubMed ID: 23829825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology and Laboratory Findings in Patients with ANCA-Associated Vasculitis].
    Wada T
    Rinsho Byori; 2015 Oct; 63(10):1213-9. PubMed ID: 26897859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitro.
    Popat RJ; Robson MG
    Ann Rheum Dis; 2019 May; 78(5):709-711. PubMed ID: 30514699
    [No Abstract]   [Full Text] [Related]  

  • 7. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
    Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
    Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L9. The role of genetic background in an animal model of ANCA-associated vasculitis.
    Xiao H
    Presse Med; 2013 Apr; 42(4 Pt 2):517-20. PubMed ID: 23465298
    [No Abstract]   [Full Text] [Related]  

  • 9. Granulocyte colony stimulating factor exacerbates antineutrophil cytoplasmic antibody vasculitis.
    Freeley SJ; Coughlan AM; Popat RJ; Dunn-Walters DK; Robson MG
    Ann Rheum Dis; 2013 Jun; 72(6):1053-8. PubMed ID: 23087180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L1. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations.
    Charles Jennette J; Falk RJ
    Presse Med; 2013 Apr; 42(4 Pt 2):493-8. PubMed ID: 23465301
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution.
    Souid M; Terki NH; Nochy D; Hillion D
    Clin Nephrol; 2001 Apr; 55(4):337-8. PubMed ID: 11334325
    [No Abstract]   [Full Text] [Related]  

  • 12. L3. Are mononuclear cells predominant actors of endothelial damage in vasculitis?
    Abdulahad WH; De Souza AW; Kallenberg CG
    Presse Med; 2013 Apr; 42(4 Pt 2):499-503. PubMed ID: 23477715
    [No Abstract]   [Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.
    Xiao H; Heeringa P; Hu P; Liu Z; Zhao M; Aratani Y; Maeda N; Falk RJ; Jennette JC
    J Clin Invest; 2002 Oct; 110(7):955-63. PubMed ID: 12370273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of p38 mitogen-activated protein kinase inhibition on anti-neutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivo.
    van der Veen BS; Chen M; Müller R; van Timmeren MM; Petersen AH; Lee PA; Satchell SC; Mathieson PW; Saleem MA; Stegeman CA; Zwerina J; Molema G; Heeringa P
    Ann Rheum Dis; 2011 Feb; 70(2):356-65. PubMed ID: 21062851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Heeringa P; Tervaert JW
    Kidney Int; 2004 May; 65(5):1564-7. PubMed ID: 15086893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
    Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
    Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
    Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
    J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of ANCA-associated vasculitis: recent insights from animal models.
    van Timmeren MM; Heeringa P
    Curr Opin Rheumatol; 2012 Jan; 24(1):8-14. PubMed ID: 22089093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L10. Animal models of ANCA-associated vasculitis: effector mechanisms and experimental therapies.
    Schreiber A
    Presse Med; 2013 Apr; 42(4 Pt 2):520-3. PubMed ID: 23453497
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.
    Xiao H; Heeringa P; Liu Z; Huugen D; Hu P; Maeda N; Falk RJ; Jennette JC
    Am J Pathol; 2005 Jul; 167(1):39-45. PubMed ID: 15972950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.